SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-056974
Filing Date
2020-05-05
Accepted
2020-05-05 17:05:25
Documents
3
Effectiveness Date
2020-05-05

Document Format Files

Seq Description Document Type Size
1 DEFA14A a20-18107_3defa14a.htm DEFA14A 33567
2 GRAPHIC g181073bci001.gif GRAPHIC 113091
3 GRAPHIC g181073bci002.gif GRAPHIC 75660
  Complete submission text file 0001104659-20-056974.txt   294228
Mailing Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6
Business Address 1111 DR. FREDERIK-PHILIPS BLVD SUITE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38899 | Film No.: 20849857
SIC: 2834 Pharmaceutical Preparations